Product
LF111
1 clinical trial
2 indications
Indication
Change in Bone Mineral DensityIndication
OsteoporosisClinical trial
A Multicenter, Open-label, Controlled Study to Investigate the Effect of Either LF111 or Drospirenone Chewable Tablets on Bone Mineral Density in Adolescent and Adult Women in Comparison With Non-users of Hormonal Contraceptive MethodsStatus: Recruiting, Estimated PCD: 2026-07-01